Back to Market Feed

Product Information

LUBIPROSTONE 8 MCG CAPSULE is a generic product labeled by Natco Pharma USA LLC, priced at $0.5493 per EA under NDC 69339016217. Its NADAC has been published 197 times since Nov 16, 2022.

FDA first approved this application on Jan 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LUBIPROSTONE 8 MCG CAPSULE

LUBIPROSTONE
$0.5493per EA

Strength

8 ug/1

NDC

69339016217

Classification

Generic

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LUBIPROSTONE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021908

FDA Approved

1/31/2006

TE Code

AB

On Market Since

10/17/2022

Pharmacological Classes

Chloride Channel Activator
Chloride Channel Activators

Price Statistics

The NADAC for LUBIPROSTONE 8 MCG CAPSULE has been published 197 times since Nov 16, 2022, and over the history we have for it it has declined 87.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5493 per EA
All-time high$4.4984 (Dec 14, 2022)
All-time low$0.5447 (Nov 20, 2024)
52-week high$0.8252
52-week low$0.5493
Median price$0.8252
Average price$1.3350
Largest weekly change-46.8% (Dec 20, 2023)
Weeks tracked197
Tracking sinceNov 16, 2022

Price History

1W

-1.3%

1M

-1.3%

3M

-23.3%

6M

-19.7%

1Y

-33.4%

3Y

-70.1%

5Y

N/A

All

-87.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LUBIPROSTONE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

LUBIPROSTONE 8 MCG CAPSULE
Generic
00254302802•Par Health USA, LLC
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
00480347906•Teva Pharmaceuticals USA Inc.
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
31722040360•Camber Pharmaceuticals Inc.
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
43598016360•Dr. Reddy's Laboratories Inc.
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
63304035160•Sun Pharmaceutical Industries Inc.
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
70710164106•Zydus Pharmaceuticals (USA) Inc.
$0.5493
per EA
LUBIPROSTONE 8 MCG CAPSULE
Generic
72603028801•NorthStar Rx LLC
$0.5493
per EA
LUBIPROSTONE 24 MCG CAPSULE
Generic
00254302902•Par Health USA, LLC
$0.6239
per EA
LUBIPROSTONE 24 MCG CAPSULE
Generic
00480413806•Teva Pharmaceuticals USA Inc.
$0.6239
per EA
LUBIPROSTONE 24 MCG CAPSULE
Generic
31722040460•Camber Pharmaceuticals Inc.
$0.6239
per EA

Frequently asked questions

What is the NADAC price of LUBIPROSTONE 8 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 8 MCG CAPSULE, manufactured by Natco Pharma USA LLC, is $0.5493 per EA (NDC 69339016217), effective Aug 19, 2026.

How has the price of LUBIPROSTONE 8 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has declined 87.5%. It has been tracked across 197 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 8 MCG CAPSULE?

Since Nov 16, 2022, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has ranged from a low of $0.5447 (Nov 20, 2024) to a high of $4.4984 (Dec 14, 2022), with a median of $0.8252 per EA.

Are there cheaper alternatives to LUBIPROSTONE 8 MCG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of LUBIPROSTONE 8 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LUBIPROSTONE 8 MCG CAPSULE?

LUBIPROSTONE 8 MCG CAPSULE (NDC 69339016217) is labeled by Natco Pharma USA LLC, and CMS classifies it as a generic product.